Article
Improved gene targeting in vivo using EoHR, a small molecule inhibitor of 53BP1
2024-06-01
Abstract excerpt
Precise genome editing by programmable nucleases such as Cas9 has revolutionised medical research by enabling the creation of gene-edited or knock-in mouse models of disease. However, a major limitation of the approach is the inefficient process of homology driven recombination (HDR) from an exogenous DNA repair template. This is because error-prone, 53BP1-dependent non-homologous end joining (NHEJ) predominates a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bea19e2f-5eac-51c7-af13-760ab0a5a323
- DOI
- 10.1101/2024.05.30.596757
